Log in

KRKG Krka, d. d., Novo mesto LJSE · Slovenia

Krka, d. d., Novo mesto (KRKG) news

Krka, d. d., Novo mesto is a public biotech or pharmaceutical company listed on LJSE under the ticker KRKG, recorded under Slovenia. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Krka, d. d., Novo mesto news

We have not published a story on Krka, d. d., Novo mesto yet. When there is news, it will appear here.

Questions about Krka, d. d., Novo mesto

What is the ticker symbol of Krka, d. d., Novo mesto?

Krka, d. d., Novo mesto trades under the ticker KRKG on LJSE.

Where is Krka, d. d., Novo mesto listed?

Krka, d. d., Novo mesto is listed on LJSE. Our directory also records these other listings: GPW:KRK; LS:903246; LSX:903246; VIE:KRKG.

Which country or territory is Krka, d. d., Novo mesto listed under?

Our directory records Krka, d. d., Novo mesto under Slovenia.

What does Krka, d. d., Novo mesto do?

Our directory classifies Krka, d. d., Novo mesto as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Krka, d. d., Novo mesto?

The ISIN recorded for Krka, d. d., Novo mesto is SI0031102120.

Does aibio.space cover Krka, d. d., Novo mesto?

aibio.space lists Krka, d. d., Novo mesto among 2,820 public biotech companies and publishes its news here as stories appear.

Investor discussion: Krka, d. d., Novo mesto

Members talk about Krka, d. d., Novo mesto (KRKG). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Listing details

Krka, d. d., Novo mesto is a public biotech or pharmaceutical company listed on LJSE under the ticker KRKG, recorded under Slovenia. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Krka, d. d., Novo mesto
Ticker
KRKG
Listing
LJSE
Country or territory
Slovenia
Business scope
Pharmaceuticals: Major
ISIN
SI0031102120
Other listed symbols
GPW:KRK; LS:903246; LSX:903246; VIE:KRKG
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.